GCP Compliance Oversight Manager, FSP
Thermo Fisher Scientific- Full Time
- Junior (1 to 2 years)
Employment Type: Full time
PTC Therapeutics is a global commercial biopharmaceutical company. For over 25 years, our team has been deeply committed to a unified purpose: Extending life’s moments for children and adults living with a rare disease.
At PTC, we cultivate an inclusive culture where everyone feels valued, respected, and empowered. We welcome candidates from all backgrounds to join our team, fostering a strong sense of belonging.
Visit our website to learn more about our company and culture! Site: www.ptcbio.com
PTC is committed to providing access to best-in-class treatments for patients with little to no treatment options. This mission underpins our focus on the discovery, development, and global commercialization of clinically differentiated medicines for those with rare diseases. As a patient-centric, global pharmaceutical company, we combine clinical and scientific expertise with groundbreaking science and technology, always with the patient in mind. We work hard to provide broad access to our life-changing treatments. What drives us is our passion to provide patients with more moments with their families.
The Director, Clinical Monitoring Oversight Lead is tasked with providing strategic leadership and overseeing clinical trial monitoring activities, ensuring adherence to regulatory standards and data integrity. This position involves crafting and executing comprehensive monitoring oversight strategies and plans and leveraging risk-based monitoring approaches. The Director, Clinical Monitoring Oversight Lead manages direct report(s). The incumbent works cross-functionally with internal and external partners to guarantee the successful monitoring of clinical trials. The Director, Clinical Monitoring Oversight Lead ensures compliance with regulatory requirements, ICH-GCP guidelines, and the company's Standard Operating Procedures (SOPs).
(No specific requirements were provided in the original text.)
(No specific application instructions were provided in the original text.)
Develops therapies for CNS disorders
Axsome Therapeutics develops therapies for central nervous system (CNS) disorders, focusing on conditions like major depressive disorder, treatment-resistant depression, and Alzheimer's agitation. Their main product, AXS-05, is an oral medication that works by blocking NMDA receptors in the brain, which helps regulate mood. This drug has shown positive results in clinical trials and has received special FDA status to speed up its approval process. Unlike many competitors, Axsome emphasizes addressing unmet medical needs in CNS disorders and aims to improve patient outcomes through rigorous research and development. The company's goal is to bring effective treatments to market, enhancing the quality of life for patients suffering from these conditions.